Presented by Michael Dennis, Innovacorp

Depending on the sector and type of technology application you are developing, assessing market potential varies. In this workshop, Michael Dennis will describe the elusive billion-dollar investment opportunity venture capitalists are looking for, including a dive into quantifying customer pain, providing various relevant examples.

Michael Dennis is an investment manager at Innovacorp, where his focus is on identifying and developing pre-seed and seed investment opportunities in the clean technology sectors. He manages all aspects of the investment review, approval and closing cycle. Michael has extensive experience in the commercialization of early stage technologies through his career as a research scientist, entrepreneur and executive in start-ups. Prior to joining Innovacorp, Michael was CEO of Performance Genomics, where he led a turn-around based on strategic partnering and financing for the company’s R&D program. He previously worked in various roles in the biotechnology industry in Atlantic Canada, including serving as CEO of Genome Atlantic, where he led development and financing of large-scale genomics research projects in the region. Michael also spent 15 years in the biotechnology industry in Montreal, where he was co-founder and CEO of a biotechnology tools company that raised several rounds of venture financing, grew to profitability, and was acquired by a US-based multinational. He was also CEO of SignalGene, a publicly traded medical genomics company for which he led private and public financings and established strategic alliances with partners in the US and EU. Michael holds a B.Sc. and M.Sc. from Dalhousie University and a doctorate in biochemistry from the Université de Montréal.

Thursday, January 28, 2021
9:00 am – 11:00 am
Via Zoom

Register in advance for this meeting:
https://innovacorp-ca.zoom.us/meeting/register/tJcvcuipqjkvGtCRgAwngpIGa...